Wikidata

(Q87405997)

English

Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

scientific article published on 04 March 2014

In more languages

Statements

title
Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24598985
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598985%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q87405997&oldid=2125665375"